Concordance of Post-consolidation Minimal Residual Disease Rates by Multiparametric Flow Cytometry and Next-generation Sequencing in CASSIOPEIA

被引：16

作者：

Avet-Loiseau, Herve ^{[1
]}

Bene, Marie C. ^{[2
]}

Wuilleme, Soraya ^{[2
]}

Corre, Jill ^{[1
]}

Attal, Michel ^{[3
]}

Arnulf, Bertrand ^{[4
]}

Garderet, Laurent ^{[5
]}

Macro, Margaret ^{[6
]}

Stoppa, Anne-Marie ^{[7
]}

Delforge, Michel ^{[8
]}

Broijl, Annemiek ^{[9
]}

Zweegman, Sonja ^{[10
]}

Jie, Kon-Siong ^{[11
]}

Van de Donk, Niels ^{[12
]}

Pei, Lixia ^{[13
]}

de Boer, Carla ^{[14
]}

Chiu, Chris ^{[15
]}

Vanquickelberghe, Veronique ^{[16
]}

Kampfenkel, Tobias ^{[14
]}

Vermeulen, Jessica ^{[14
]}

Moreau, Philippe ^{[17
]}

Sonneveld, Pieter ^{[9
]}

机构：

[1] IUC T Oncopole, Unite Genom Myelome, Toulouse, France

[2] Univ Hosp Hotel Dieu, Hematol Biol, Nantes, France

[3] Inst Univ Canc Toulouse Oncopole, Toulouse, France

[4] Hop St Louis, Hematol Oncol, Paris, France

[5] Sorbonne Univ, INSERM, Paris, France

[6] CHU Caen, Caen, France

[7] Inst Paoli Calmettes, Marseille 9, France

[8] Univ Ziekenhuizen Leuven, Leuven, Belgium

[9] Erasmus MC Canc Inst, Rotterdam, Netherlands

[10] Vrije Univ Amsterdam, Amsterdam UMC, Dept Hematol, Amsterdam, Netherlands

[11] Zuyderland MC, Sittard, Netherlands

[12] Vrije Univ Amsterdam Med Ctr, Dept Hematol, Amsterdam, Netherlands

[13] Janssen Res & Dev LLC, Raritan, NJ USA

[14] Janssen Res & Dev LLC, Leiden, Netherlands

[15] Janssen Res & Dev LLC, Spring House, PA USA

[16] Janssen Res & Dev, Beerse, Belgium

[17] Univ Hosp Hotel Dieu, Hematol, Nantes, France

来源：

CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2019年 / 19卷 / 10期

关键词：

daratumumab; Multiple myeloma; transplant;

D O I：

10.1016/j.clml.2019.09.005

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

OAB-004

引用

页码：E3 / E4

页数：2

共 50 条

[21] Monitoring of minimal residual disease in acute leukemia by multiparametric flow cytometry
Kusenda, J.
Fajtova, M.
Kovarikova, A.
NEOPLASMA, 2014, 61 (02) : 119 - 127
[22] Upgraded Standardized Minimal Residual Disease Detection by Next-Generation Sequencing in Multiple Myeloma
Yao, Qiumei
Bai, Yinlei
Orfao, Alberto
Kumar, Shaji
Chim, Chor S.
JOURNAL OF MOLECULAR DIAGNOSTICS, 2020, 22 (05): : 679 - 684
[23] Next-generation sequencing in the diagnosis and minimal residual disease assessment of acute myeloid leukemia
Levine, Ross L.
Valk, Peter J. M.
HAEMATOLOGICA, 2019, 104 (05) : 868 - 871
[24] Comparison of Minimal Residual Disease Detection in Autografts of Patients with Multiple Myeloma between 8-Color Multiparameter Flow Cytometry (EuroFlow) and Next-Generation Sequencing
Takamatsu, Hiroyuki
Takezako, Naoki
Wee, Rachel K.
Yoroidaka, Takeshi
Yamashita, Takeshi
Murata, Ryoichi
Matsue, Kosei
Nakao, Shinji
BLOOD, 2018, 132
[25] Prospective evaluation of minimal residual disease in the phase II FORTE trial: a head-to-head comparison between multiparameter flow cytometry and next-generation sequencing
Oliva, Stefania
Genuardi, Elisa
Paris, Laura
D'Agostino, Mattia
Rogers, Jennifer
Rota-Scalabrini, Delia
Jacob, Allison P.
Patriarca, Francesca
Luppi, Mario
Bertazzoni, Paola
Velluti, Cristina
Capra, Andrea
Saraci, Elona
Rossi, Marco
Allegra, Alessandro
Mina, Roberto
Gentile, Massimo
Kirsch, Ilan R.
Belotti, Angelo
Cavo, Michele
Bruno, Benedetto
Musto, Pellegrino
Boccadoro, Mario
Zamagni, Elena
Gay, Francesca
ECLINICALMEDICINE, 2023, 60
[26] NEXT-GENERATION SEQUENCING AS A TOOL FOR ASSESSING MINIMAL RESIDUAL DISEASE IN AML PATIENTS WITH CEBPA MUTATIONS
Zejskova, L.
Plachy, R.
Sedlackova, L.
Mazal, O.
Ondrackova, M.
Zavrelova, A.
Zak, P.
Petecukova, V.
Novak, J.
Kozak, T.
Pekova, S.
HAEMATOLOGICA, 2015, 100 : 358 - 359
[27] Detection of Fusion Genes to Determine Minimal Residual Disease in Leukemia Using Next-Generation Sequencing
de Boer, Eddy N.
Johansson, Lennart F.
de Lange, Kim
Bosga-Brouwer, Anneke G.
van den Berg, Eva
Sikkema-Raddatz, Birgit
van Diemen, Cleo C.
CLINICAL CHEMISTRY, 2020, 66 (08) : 1084 - 1092
[28] Evaluation of minimal residual disease using next generation flow cytometry in patients with AL amyloidosis
Kastritis, Efstathios
Fotiou, Despina
Kostopoulos, Ioannis
Theodorakakou, Foteini
Terpos, Evangelos
Gavriatopoulou, Maria
Spiliopoulou, Vasiliki
Ntanasis-Stathopoulos, Ioannis
Malandrakis, Panagiotis
Kanellias, Nikolaos
Roussou, Maria
Magdalini, Migkou
Eleutherakis-Papaiakovou, Evangelos
Solia, Eirini
Papathoma, Alexandra
Tsitsilonis, Ourania
Dimopoulos, Meletios Athanasios
AMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS, 2024, 31 : S62 - S62
[29] Evaluation of Minimal Residual Disease Using Next Generation Flow Cytometry in Patients With AL Amyloidosis
Theodorakakou, Foteini
Fotiou, Despina
Kostopoulos, Ioannis
Terpos, Evangelos
Gavriatopoulou, Maria
Spiliopoulou, Vasiliki
Ntanasis-Stathopoulos, Ioannis
Malandrakis, Panagiotis
Kanellias, Nikolaos
Roussou, Maria
Migkou, Magdalini
Eleutherakis-Papaiakovou, Evangelos
Solia, Eirini
Papathoma, Alexandra
Tsitsiloni, Ourania
Dimopoulos, Meletios-Athanasios
Kastritis, Efstathios
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S576 - S576
[30] Next-Generation Sequencing of NPM1 for Minimal Residual Disease Monitoring in Leukemia Patients
Carson, A. R.
Xie, Z.
McClain, V.
Miller, J. E.
Stenzel, T.
JOURNAL OF MOLECULAR DIAGNOSTICS, 2016, 18 (06): : 967 - 967

← 1 2 3 4 5 →